Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Dill

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Carcinogenesis|August 1, 2013
Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53François H T Duong, Michael T Dill, Matthias S Matter, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Gene expression analysis of biopsy samples reveals critical limitations of transcriptome-based molecular classifications of hepatocellular carcinomaZuzanna Makowska, Tujana Boldanova, David Adametz, et al.
Gastroenterology|November 30, 2010
Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis CMichael T Dill, Francois H T Duong, Julia E Vogt, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 19, 2016
Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulationChristine Bernsmeier, Michael T Dill, Angela Provenzano, et al.
Nature Communications|November 18, 2018
NUAK2 is a critical YAP target in liver cancerWei-Chien Yuan, Brian Pepe-Mooney, Giorgio G Galli, et al.
EMBO Molecular Medicine|October 19, 2021
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosisRuize Gao, Ravi K R Kalathur, Mairene Coto-Llerena, et al.
British Journal of Cancer|August 19, 2022
Precision oncology for intrahepatic cholangiocarcinoma in clinical practiceAurelie Tomczak, Christoph Springfeld, Michael T Dill, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2012
Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis CStéphanie Pascarella, Sophie Clément, Michael T Dill, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 19, 2025
Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACENan Wei, René Michael Mathy, De-Hua Chang, et al.
Hepatology (Baltimore, Md.)|July 23, 2013
Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cellsAnne Frentzen, Anggakusuma, Engin Gürlevik, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Carcinogenesis|August 1, 2013
Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53François H T Duong, Michael T Dill, Matthias S Matter, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Gene expression analysis of biopsy samples reveals critical limitations of transcriptome-based molecular classifications of hepatocellular carcinomaZuzanna Makowska, Tujana Boldanova, David Adametz, et al.
Gastroenterology|November 30, 2010
Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis CMichael T Dill, Francois H T Duong, Julia E Vogt, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 19, 2016
Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulationChristine Bernsmeier, Michael T Dill, Angela Provenzano, et al.
Nature Communications|November 18, 2018
NUAK2 is a critical YAP target in liver cancerWei-Chien Yuan, Brian Pepe-Mooney, Giorgio G Galli, et al.
EMBO Molecular Medicine|October 19, 2021
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosisRuize Gao, Ravi K R Kalathur, Mairene Coto-Llerena, et al.
British Journal of Cancer|August 19, 2022
Precision oncology for intrahepatic cholangiocarcinoma in clinical practiceAurelie Tomczak, Christoph Springfeld, Michael T Dill, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2012
Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis CStéphanie Pascarella, Sophie Clément, Michael T Dill, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 19, 2025
Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACENan Wei, René Michael Mathy, De-Hua Chang, et al.
Hepatology (Baltimore, Md.)|July 23, 2013
Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cellsAnne Frentzen, Anggakusuma, Engin Gürlevik, et al.
Pageof 5